Does it fit in your pocket? economic burden of PD-1 inhibitors' toxicity in the supplementary health system: evidence from Brazil.

BMC Health Serv Res · 2023 · PMC10360250 · PMID 37480058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Cost comparisons with regard to tumor types showed a trend towards higher CMO and TMC for malignant kidney neoplasms and lower CMO and TMC for malignant bladder neoplasms, which has not been described in the literature to the best of our knowledge.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.